The recent discovery of mutations in DICER1, STK11 and FOXL2 genes has improved our understanding in addition to the approach to sex cord stromal tumours and can serve as diagnostic and prognostic markers [15] and may assist in risk stratification in the future. The gene discussed is FOXL2; the disease is neoplasm.